Sargent Bickham Lagudis LLC Homology Medicines, Inc. Put Options Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FIXX
# of Institutions
5Shares Held
66.2KCall Options Held
0Put Options Held
0About Homology Medicines, Inc.
- Ticker FIXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,402,000
- Description
- Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...